(Q33350682)

English

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

author name string

László Herszényi

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Fabio Farinati

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Romilda Cardin

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Gábor István

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

László D Molnár

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Massimo De Paoli

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Mario Plebani

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Zsolt Tulassay

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

10 July 2008

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

194

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prognostic factors of young patients with colon cancer after surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prediagnostic Levels of Carcinoembryonic Antigen and CA 242 in Colorectal Cancer: A Matched Case-Control Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Carcinoembryonic antigen and recurrent colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

The clinical relevance of tumor marker CEA, CA 19-9 in regional chemotherapy of hepatic metastases of colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Cathepsin B and cystatins: evidence for a role in cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Tumor invasion and metastasis: an imbalance of positive and negative regulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

21 June 2018

Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

The expression of low density lipoprotein receptor-related protein in colorectal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474636

31 October 2018

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-194

21 January 2018

Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients with colorectal carcinoma: possible prognostic value of tissular carbohydrate antigen 19.9 determination

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the colon: the influence of the no-touch isolation technic on survival rates

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cysteine and serine proteases in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cysteine and serine proteases in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18616803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-194

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18616803%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33350682&oldid=2195271742"